Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Titel:
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Auteur:
Hurvitz, Sara A Martin, Miguel Symmans, W Fraser Jung, Kyung Hae Huang, Chiun-Sheng Thompson, Alastair M Harbeck, Nadia Valero, Vicente Stroyakovskiy, Daniil Wildiers, Hans Campone, Mario Boileau, Jean-François Beckmann, Matthias W Afenjar, Karen Fresco, Rodrigo Helms, Hans-Joachim Xu, Jin Lin, Yvonne G Sparano, Joseph Slamon, Dennis